Reversible bevacizumab induced vocal fold necrosis

A Sulibhavi, S Tharmalingam, L McCarroll… - Journal of Voice, 2023 - Elsevier
Background As the use of anti-angiogenic treatments is gaining scope in the treatment of
various malignancies, there are increasing reports of laryngeal side effects. We report two …
被引用次数：3 相关文章

Reversible Bevacizumab Induced Vocal Fold Necrosis.

A Sulibhavi, S Tharmalingam, L McCarroll… - Journal of Voice …, 2020 - europepmc.org
As the use of anti-angiogenic treatments is gaining scope in the treatment of various
malignancies, there are increasing reports of laryngeal side effects. We report two cases of …

Reversible Bevacizumab Induced Vocal Fold Necrosis

A Sulibhavi, S Tharmalingam… - Journal of voice …, 2023 - pubmed.ncbi.nlm.nih.gov
Background As the use of anti-angiogenic treatments is gaining scope in the treatment of
various malignancies, there are increasing reports of laryngeal side effects. We report two …

Reversible Bevacizumab Induced Vocal Fold Necrosis

A Sulibhavi, S Tharmalingam, L McCarroll… - Journal of Voice, 2023 - jvoice.org
Background As the use of anti-angiogenic treatments is gaining scope in the treatment of
various malignancies, there are increasing reports of laryngeal side effects. We report two …